Prevalence of hepatitis C virus infection in patients with chronic mental disorders: The relevance of dual disorders

Zaltron, 2012, Chronic HCV infection: epidemiological and clinical relevance, BMC Infect Dis, 12, 1, 10.1186/1471-2334-12-S2-S2 Alqahtani, 2020, Viral hepatitis as a risk factor for the development of hepatocellular carcinoma, Hepatoma Res, 6, 1 Suresh, 2020, Etiology of hepatocellular carcinoma: special focus on fatty liver disease, Front Oncol, 10, 601710, 10.3389/fonc.2020.601710 Pocha, 2019, Hepatocellular carcinoma in alcoholic and non-alcoholic fatty liver disease-one of a kind or two different enemies?, Transl Gastroenterol Hepatol, 4, 72, 10.21037/tgh.2019.09.01 2017 Gower, 2014, Global epidemiology and genotype distribution of the hepatitis C virus infection, J Hepatol, 61, S45, 10.1016/j.jhep.2014.07.027 Estirado Gómez, 2019 Rodriguez-Tajes, 2020, Significant decrease in the prevalence of hepatitis C infection after the introduction of direct acting antivirals, J Gastroenterol Hepatol, 35, 1570, 10.1111/jgh.14984 Więdłocha, 2017, The neuropsychiatric aspect of the HCV infection, Adv Clin Exp Med, 26, 167, 10.17219/acem/37787 Rifai, 2010, Psychiatric care of the patient with hepatitis C: a review of the literature, Prim Care Companion J Clin Psychiatry, 12 Sylvestre, 2004, Co-occurring hepatitis C, substance use, and psychiatric illness: treatment issues and developing integrated models of care, J Urban Health, 81, 719, 10.1093/jurban/jth153 Hughes, 2016, Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness: a systematic review and meta-analysis, Lancet Psychiatry, 3, 40, 10.1016/S2215-0366(15)00357-0 Daigre, 2017, The role of dual diagnosis in health-related quality of life among treatment-seeking patients in Spain, Qual Life Res, 26, 3201, 10.1007/s11136-017-1668-4 Schaefer, 2012, Hepatitis C infection, antiviral treatment and mental health: a European expert consensus statement, J Hepatol, 57, 1379, 10.1016/j.jhep.2012.07.037 Pineda, 2020, Executive summary: Consensus document of GEHEP of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), along with SOCIDROGALCOHOL, SEPD and SOMAPA on hepatitis C virus infection management in drug users, Enferm Infecc Microbiol Clin, 38, 127, 10.1016/j.eimc.2018.09.006 Roncero, 2017, Chronic hepatitis C and individuals with a history of injecting drugs in Spain: population assessment, challenges for successful treatment, Eur J Gastroenterol Hepatol, 29, 629, 10.1097/MEG.0000000000000855 Aghemo, 2021, Real-world outcomes in historically underserved patients with chronic hepatitis C infection treated with glecaprevir/pibrentasvir, Infect Dis Ther, 10, 2203, 10.1007/s40121-021-00455-1 Giraudon, 2016 Lacey, 2007, Hepatitis C in psychiatry inpatients: testing rates, prevalence and risk behaviours, Australas Psychiatry, 15, 315, 10.1080/10398560701358113 Lin, 2017, Association of Alzhemier's disease with hepatitis C among patients with bipolar disorder, PLoS One, 12, e0179312, 10.1371/journal.pone.0179312 Ramachandran, 2019, Hepatitis C virus infection in Australian psychiatric inpatients: a multicenter study of seroprevalence, risk factors and treatment experience, J Viral Hepat, 26, 609, 10.1111/jvh.13056 Fernández-Egea, 2002, Serological testing and prevalence of human immunodeficiency, hepatitis B and C viruses infections amongst acute psychiatric inpatients, Med Clin (Barc), 119, 690, 10.1016/S0025-7753(02)73543-4 Roncero, 2019, Practical steps to improve chronic hepatitis C treatment in people with opioid use disorder, Hepat Med, 11, 1 Gutiérrez-Rojas L, de la Gándara Martín JJ, Garcia Buey L, Uriz Otano JI, Mena Á, Roncero C. Patients with severe mental illness and hepatitis C virus infection benefit from new pangenotypic direct-acting antivirals: results of a literature review. Gastroenterol Hepatol 2022:S0210-5705(22)00164-9, https://doi.org/10.1016/j.gastrohep.2022.06.001 Rhodes, 2008, HCV in incarcerated populations: an analysis of gender and criminality on risk, J Psychoactive Drugs, 40, 493, 10.1080/02791072.2008.10400655